Kuhn & Co Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.96M Buy
3,221
+20
+0.6% +$20.3K 1.91% 11
2025
Q4
$3.44M Sell
3,201
-99
-3% -$94.7K 2.29% 9
2025
Q3
$2.52M Sell
3,300
-45
-1% -$33.5K 1.99% 11
2025
Q2
$2.61M Hold
3,345
1.97% 10
2025
Q1
$2.76M Sell
3,345
-231
-6% -$192K 2.33% 8
2024
Q4
$2.76M Sell
3,576
-95
-3% -$78.7K 2.35% 9
2024
Q3
$3.25M Sell
3,671
-31
-0.8% -$27.9K 2.77% 6
2024
Q2
$3.35M Hold
3,702
3.01% 6
2024
Q1
$2.88M Sell
3,702
-359
-9% -$255K 2.71% 7
2023
Q4
$2.37M Buy
+4,061
New +$2.37M 2.43% 6

Other funds holding LLY

Kuhn & Co Investment Counsel's LLY Position: Q1 2026 in Review

Kuhn & Co Investment Counsel increased its Eli Lilly (LLY) stake by 0.62% in Q1 2026, buying an estimated $20.3K and bringing the position to 3,221 shares worth $2.96M. The position accounts for 1.91% of the portfolio, ranked #11.

Kuhn & Co Investment Counsel first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.44M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kuhn & Co Investment Counsel held 3,221 shares of Eli Lilly worth $2.96M as of Q1 2026.
  • Kuhn & Co Investment Counsel bought 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 1.91% of Kuhn & Co Investment Counsel's portfolio in Q1 2026, its #11 holding.
  • Kuhn & Co Investment Counsel first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Kuhn & Co Investment Counsel's Eli Lilly position peaked at $3.44M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kuhn & Co Investment Counsel's 13F filing for Q1 2026, filed 12 May 2026.